2 Top Stocks to Buy and Hold for the Long Term [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Shopify's long-term ambitions are off to a great start, given its large addressable market and economic moat. 10 stocks we like better than Novartis › Long-term investing is easy and relatively stress-free, at least in principle. All you have to do is purchase shares of quality companies and sit back and watch for years -- sometimes decades -- as the value of your investment rises. However, there are several factors that make this strategy somewhat more complicated than it appears. One of them is the challenge of picking which stocks to invest in. Making the wrong choice will not lead to a stress-free ride -- quite the opposite. In that spirit, let's consider two companies that are solid long-term investment candidates: Novartis (NYSE: NVS) and Shopify (NASDAQ: SHOP) While medical drugs will always be in high demand, not every pharmaceutical company is a worthwhile long-term investment. Novartis, though, is. Let's consider several reasons. First, it has proved to be highly
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Nine Drugmakers Strike Deals With Trump, More Coming Next Year [Yahoo! Finance]Yahoo! Finance
- Novartis and US government reach agreement on lowering drug prices in the US [Yahoo! Finance]Yahoo! Finance
- Novartis' myasthenia gravis asset iptacopan granted FDA Orphan Drug status [Seeking Alpha]Seeking Alpha
- Corporate director convicted of insider trading [Investment Executive - News]Investment Executive - News
- Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 10/28/25 - Miss
NVS
Sec Filings
- 11/25/25 - Form 6-K
- 11/20/25 - Form 6-K
- 11/5/25 - Form 6-K
- NVS's page on the SEC website